Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
HTS_SELF |
|
2019 |
598 |
HTS_SELF |
|
2019 |
141,404 |
HTS_SELF |
10-14, Female, Directly-Assisted |
2019 |
87 |
HTS_SELF |
15-19, Female, Directly-Assisted |
2019 |
32 |
HTS_SELF |
15-19, Female, Directly-Assisted |
2019 |
7,575 |
HTS_SELF |
15-19, Female, Unassisted |
2019 |
32 |
HTS_SELF |
15-19, Female, Unassisted |
2019 |
7,575 |
HTS_SELF |
15-19, Male, Directly-Assisted |
2019 |
11 |
HTS_SELF |
15-19, Male, Directly-Assisted |
2019 |
2,526 |
HTS_SELF |
15-19, Male, Unassisted |
2019 |
11 |
HTS_SELF |
15-19, Male, Unassisted |
2019 |
2,526 |
HTS_SELF |
20-24, Female, Directly-Assisted |
2019 |
32 |
HTS_SELF |
20-24, Female, Directly-Assisted |
2019 |
7,487 |
HTS_SELF |
20-24, Female, Unassisted |
2019 |
32 |
HTS_SELF |
20-24, Female, Unassisted |
2019 |
7,575 |
HTS_SELF |
20-24, Male, Directly-Assisted |
2019 |
11 |
HTS_SELF |
20-24, Male, Directly-Assisted |
2019 |
2,526 |
HTS_SELF |
20-24, Male, Unassisted |
2019 |
11 |
HTS_SELF |
20-24, Male, Unassisted |
2019 |
2,526 |
HTS_SELF |
25-29, Female, Directly-Assisted |
2019 |
32 |
HTS_SELF |
25-29, Female, Directly-Assisted |
2019 |
7,575 |
HTS_SELF |
25-29, Female, Unassisted |
2019 |
32 |
HTS_SELF |
25-29, Female, Unassisted |
2019 |
7,575 |
HTS_SELF |
25-29, Male, Directly-Assisted |
2019 |
11 |
HTS_SELF |
25-29, Male, Directly-Assisted |
2019 |
2,526 |
HTS_SELF |
25-29, Male, Unassisted |
2019 |
11 |
HTS_SELF |
25-29, Male, Unassisted |
2019 |
2,526 |
HTS_SELF |
30-34, Female, Directly-Assisted |
2019 |
32 |
HTS_SELF |
30-34, Female, Directly-Assisted |
2019 |
7,575 |
HTS_SELF |
30-34, Female, Unassisted |
2019 |
32 |
HTS_SELF |
30-34, Female, Unassisted |
2019 |
7,575 |
HTS_SELF |
30-34, Male, Directly-Assisted |
2019 |
11 |
HTS_SELF |
30-34, Male, Directly-Assisted |
2019 |
2,526 |
HTS_SELF |
30-34, Male, Unassisted |
2019 |
11 |
HTS_SELF |
30-34, Male, Unassisted |
2019 |
2,526 |
HTS_SELF |
35-39, Female, Directly-Assisted |
2019 |
32 |
HTS_SELF |
35-39, Female, Directly-Assisted |
2019 |
7,575 |
HTS_SELF |
35-39, Female, Unassisted |
2019 |
32 |
HTS_SELF |
35-39, Female, Unassisted |
2019 |
7,575 |
HTS_SELF |
35-39, Male, Directly-Assisted |
2019 |
11 |
HTS_SELF |
35-39, Male, Directly-Assisted |
2019 |
2,526 |
HTS_SELF |
35-39, Male, Unassisted |
2019 |
11 |
HTS_SELF |
35-39, Male, Unassisted |
2019 |
2,526 |
HTS_SELF |
40-49, Female, Directly-Assisted |
2019 |
32 |
HTS_SELF |
40-49, Female, Directly-Assisted |
2019 |
7,575 |
HTS_SELF |
40-49, Female, Unassisted |
2019 |
32 |
HTS_SELF |
40-49, Female, Unassisted |
2019 |
7,575 |
HTS_SELF |
40-49, Male, Directly-Assisted |
2019 |
11 |
HTS_SELF |
40-49, Male, Directly-Assisted |
2019 |
2,526 |
HTS_SELF |
40-49, Male, Unassisted |
2019 |
11 |
HTS_SELF |
40-49, Male, Unassisted |
2019 |
2,526 |
HTS_SELF |
50+, Female, Directly-Assisted |
2019 |
32 |
HTS_SELF |
50+, Female, Directly-Assisted |
2019 |
7,575 |
HTS_SELF |
50+, Female, Unassisted |
2019 |
32 |
HTS_SELF |
50+, Female, Unassisted |
2019 |
7,575 |
HTS_SELF |
50+, Male, Directly-Assisted |
2019 |
11 |
HTS_SELF |
50+, Male, Directly-Assisted |
2019 |
2,526 |
HTS_SELF |
50+, Male, Unassisted |
2019 |
11 |
HTS_SELF |
50+, Male, Unassisted |
2019 |
2,526 |
HTS_SELF |
Directly-Assisted |
2019 |
299 |
HTS_SELF |
Directly-Assisted |
2019 |
70,702 |
HTS_SELF |
FSW, Directly-Assisted |
2019 |
401 |
HTS_SELF |
FSW, Directly-Assisted |
2019 |
94,740 |
HTS_SELF |
MSM, Directly-Assisted |
2019 |
90 |
HTS_SELF |
MSM, Directly-Assisted |
2019 |
21,209 |
HTS_SELF |
PWID, Directly-Assisted |
2019 |
36 |
HTS_SELF |
PWID, Directly-Assisted |
2019 |
8,485 |
HTS_SELF |
Unassisted |
2019 |
299 |
HTS_SELF |
Unassisted |
2019 |
70,702 |
HTS_SELF |
Unassisted - Other |
2019 |
30 |
HTS_SELF |
Unassisted - Other |
2019 |
7,069 |
HTS_SELF |
Unassisted - Self |
2019 |
150 |
HTS_SELF |
Unassisted - Self |
2019 |
35,349 |
HTS_SELF |
Unassisted - Sex Partner |
2019 |
120 |
HTS_SELF |
Unassisted - Sex Partner |
2019 |
28,283 |
HTS_TST |
25-29, Female, Negative |
2019 |
4,401 |
HTS_TST |
25-29, Female, Negative |
2019 |
1,568 |
HTS_TST |
25-29, Female, Negative |
2019 |
58 |
HTS_TST |
25-29, Male, Negative |
2019 |
1,078 |
HTS_TST |
25-29, Male, Negative |
2019 |
368 |
HTS_TST |
25-29, Male, Negative |
2019 |
20 |
HTS_TST |
30-34, Female, Negative |
2019 |
5,026 |
HTS_TST |
30-34, Female, Negative |
2019 |
1,793 |
HTS_TST |
30-34, Female, Negative |
2019 |
67 |
HTS_TST |
30-34, Male, Negative |
2019 |
1,304 |
HTS_TST |
30-34, Male, Negative |
2019 |
445 |
HTS_TST |
30-34, Male, Negative |
2019 |
24 |
HTS_TST |
35-39, Female, Negative |
2019 |
1,255 |
HTS_TST |
35-39, Female, Negative |
2019 |
450 |
HTS_TST |
35-39, Female, Negative |
2019 |
16 |
HTS_TST |
35-39, Male, Negative |
2019 |
1,304 |
HTS_TST |
35-39, Male, Negative |
2019 |
445 |
HTS_TST |
35-39, Male, Negative |
2019 |
24 |
HTS_TST |
40-49, Female, Negative |
2019 |
16 |
HTS_TST |
40-49, Female, Negative |
2019 |
1,255 |
HTS_TST |
40-49, Female, Negative |
2019 |
450 |
HTS_TST |
40-49, Male, Negative |
2019 |
8 |
HTS_TST |
40-49, Male, Negative |
2019 |
436 |
HTS_TST |
40-49, Male, Negative |
2019 |
149 |
HTS_TST |
By Key Population: FSW, Negative |
2019 |
33,119 |
HTS_TST |
By Key Population: FSW, Negative |
2019 |
463 |
HTS_TST |
By Key Population: MSM, Negative |
2019 |
5,428 |
HTS_TST |
By Key Population: MSM, Negative |
2019 |
2 |
HTS_TST |
By Key Population: PWID, Negative |
2019 |
272 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2019 |
53,443 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2019 |
795 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative |
2019 |
3,390 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative |
2019 |
67 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative |
2019 |
1,570 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative |
2019 |
58 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative |
2019 |
11,669 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative |
2019 |
232 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative |
2019 |
5,196 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative |
2019 |
183 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative |
2019 |
631 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative |
2019 |
8 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative |
2019 |
214 |
HTS_TST |
Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative |
2019 |
4 |
HTS_TST |
Service Delivery Point (Community) VCT Mod: 15-19, Female, Negative |
2019 |
1,052 |
HTS_TST |
Service Delivery Point (Community) VCT Mod: 15-19, Male, Negative |
2019 |
737 |
HTS_TST |
Service Delivery Point (Community) VCT Mod: 20-24, Female, Negative |
2019 |
3,625 |
HTS_TST |
Service Delivery Point (Community) VCT Mod: 20-24, Male, Negative |
2019 |
2,421 |
HTS_TST |
Service Delivery Point (Community) VCT Mod: 50+, Female, Negative |
2019 |
223 |
HTS_TST |
Service Delivery Point (Community) VCT Mod: 50+, Male, Negative |
2019 |
74 |
HTS_TST_POS |
25-29, Female, Positive |
2019 |
69 |
HTS_TST_POS |
25-29, Female, Positive |
2019 |
29 |
HTS_TST_POS |
25-29, Female, Positive |
2019 |
1 |
HTS_TST_POS |
25-29, Male, Positive |
2019 |
23 |
HTS_TST_POS |
25-29, Male, Positive |
2019 |
12 |
HTS_TST_POS |
30-34, Female, Positive |
2019 |
80 |
HTS_TST_POS |
30-34, Female, Positive |
2019 |
34 |
HTS_TST_POS |
30-34, Female, Positive |
2019 |
1 |
HTS_TST_POS |
30-34, Male, Positive |
2019 |
28 |
HTS_TST_POS |
30-34, Male, Positive |
2019 |
13 |
HTS_TST_POS |
35-39, Female, Positive |
2019 |
20 |
HTS_TST_POS |
35-39, Female, Positive |
2019 |
10 |
HTS_TST_POS |
35-39, Male, Positive |
2019 |
28 |
HTS_TST_POS |
35-39, Male, Positive |
2019 |
13 |
HTS_TST_POS |
40-49, Female, Positive |
2019 |
20 |
HTS_TST_POS |
40-49, Female, Positive |
2019 |
10 |
HTS_TST_POS |
40-49, Male, Positive |
2019 |
9 |
HTS_TST_POS |
40-49, Male, Positive |
2019 |
4 |
HTS_TST_POS |
By Key Population: FSW, Positive |
2019 |
1,188 |
HTS_TST_POS |
By Key Population: FSW, Positive |
2019 |
7 |
HTS_TST_POS |
By Key Population: MSM, Positive |
2019 |
158 |
HTS_TST_POS |
By Key Population: PWID, Positive |
2019 |
4 |
HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive |
2019 |
55 |
HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive |
2019 |
1 |
HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive |
2019 |
23 |
HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive |
2019 |
1 |
HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive |
2019 |
175 |
HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive |
2019 |
3 |
HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive |
2019 |
79 |
HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive |
2019 |
3 |
HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive |
2019 |
4 |
HTS_TST_POS |
Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive |
2019 |
2 |
HTS_TST_POS |
Service Delivery Point (Community) VCT Mod: 15-19, Female, Positive |
2019 |
8 |
HTS_TST_POS |
Service Delivery Point (Community) VCT Mod: 15-19, Male, Positive |
2019 |
13 |
HTS_TST_POS |
Service Delivery Point (Community) VCT Mod: 20-24, Female, Positive |
2019 |
97 |
HTS_TST_POS |
Service Delivery Point (Community) VCT Mod: 20-24, Male, Positive |
2019 |
55 |
HTS_TST_POS |
Service Delivery Point (Community) VCT Mod: 50+, Female, Positive |
2019 |
1 |
KP_PREV |
By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2019 |
72,966 |
KP_PREV |
By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2019 |
250 |
KP_PREV |
By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2019 |
76 |
KP_PREV |
By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2019 |
4,913 |
KP_PREV |
By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2019 |
8,740 |
KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2019 |
86,695 |
KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2019 |
250 |
PP_PREV |
25-29, Male |
2019 |
21 |
PP_PREV |
30-34, Male |
2019 |
21 |
PP_PREV |
35-39, Male |
2019 |
21 |
PP_PREV |
40-49, Male |
2019 |
21 |
PP_PREV |
Age/sex: 10-14 Female |
2019 |
18 |
PP_PREV |
Age/sex: 10-14 Male |
2019 |
5 |
PP_PREV |
Age/sex: 15-19 Male |
2019 |
20 |
PP_PREV |
Age/sex: 20-24 Male |
2019 |
71 |
PP_PREV |
Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period |
2019 |
212 |
PP_PREV |
Sum of Age/Sex disaggregates |
2019 |
114 |